Dr. Noura Choudhury is a highly skilled and compassionate medical oncologist dedicated to providing exceptional care to patients with thoracic and head and neck malignancies. Dr. Choudhury is also a clinical and translational investigator, with a particular focus in small cell lung cancer. Her expertise is grounded in years of dedicated experience, which allows her to provide personalized care that addresses each patient’s unique needs.

Using a patient-centered approach to care, Dr. Choudhury ensures that each treatment plan is tailored to her patients’ specific condition, symptoms, lifestyle and healthcare goals. By integrating the latest advancements in cancer care, she strives to enhance the overall well-being of her patients. She has expertise in standard of care treatments such as chemotherapy, immunotherapy and targeted therapies, as well as novel therapeutics such as bispecific T cell engagers, antibody drug conjugates and bispecific antibodies.

In additional to her clinical work, Dr. Choudhury actively develops clinical trials, contributing to the advancement of cancer treatment. She is national Principal Investigator of an investigator-initiated National Cancer Institute (NCI) phase I/II study in small cell lung cancer, as well as the principal investigator of multiple phase I clinical trials, including first-in-human studies of novel therapeutics. She is a translational physician scientist who strives to bring discoveries in the laboratory to patients in the clinic. Her involvement in leading-edge research allows her to offer her patients access to new therapies and innovative treatments, improving their outcomes and quality of life. Her work also focuses on identifying mechanisms of response and resistance to novel treatment strategies. She is an author on numerous publications, with her work has been published in The Lancet, Clinical Cancer Research, Journal of Thoracic Oncology, Journal of Clinical Oncology, Annals of Oncology, among others.